Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in Horizon Europe actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows:

• at least one independent legal entity established in a Member State;
• and at least two other independent legal entities, each established in different Member States or Associated Countries (this includes the UK).

Our European team can help you find eligible partners to form a consortium.

There may be further eligibility conditions for specific topics. Please check the Work Programme and contact our team to ensure your eligibility before applying.

The Info Day for Cluster 1: Health is on Tuesday 10 Feb 2026, starting at 9am CET (8am UK time). An online brokerage event for consortium building is also being held, running 26-30 January 2026: registration is open until 21 January 2026.

For health organisations working in the area of cancer, the Info Days for the Horizon Europe Missions (including the Cancer Mission) are on Tuesday 20 and Wednesday 21 January, starting at 8am UK time, with an online brokerage event for Missions participants running 28-29 January.

The expected impact is that people of all ages in the EU stay healthy, resilient, and independent even as society changes fast. This will arise from healthier lifestyles and behaviour, healthier diets, healthier environments, improved evidence-informed health policies, and more effective solutions for health and wellbeing promotion, disease prevention and monitoring, and rehabilitation.

Single-stage calls opening Feb 2026, deadline 16 Apr 2026

• HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people. c. €9m-€10m per project for up to 2 projects.
• HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences. €1.5m-€1.9m for a single project.

Single-stage call opening Feb 2027, deadline 13 Apr 2027

• HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion. c. €6m-€8m per project for up to 5 projects.

The expected impact is that people’s living and working environments are health-promoting and sustainable thanks to a better understanding of the environmental, occupational, social, sex and gender-related, and economic determinants of health.

Single-stage calls opening Feb 2026, deadline 16 Apr 2026

• HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health. c. €7m-€8m per project for up to 7 projects.
• HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems. c. €7m-€8m per project for up to 6 projects.
• HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research. c. €3m for a single project.

Single-stage calls opening Feb 2027, deadline 13 Apr 2027

• HORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change. c. €10m-€11m per project for up to 4 projects.
• HORIZON-HLTH-2027-01-ENVHLTHMISSCLIMA-03: Tools and technologies to support health adaptation to climate change. c. €4m-€5m per project for up to 4 projects.

The expected impact is that healthcare providers improve their ability to tackle and manage diseases (infectious diseases, including poverty-related and neglected diseases, non-communicable and rare diseases) thereby reducing the disease burden on patients and enabling healthcare systems to perform more effectively. It can be achieved through better understanding, prevention, diagnostics, treatment, management, and cure of diseases and their co- and multi-morbidities, more effective and innovative health technologies and medical countermeasures, better ability and preparedness to manage pandemic and/or epidemic outbreaks, and improved patient safety.

Single-stage calls opening Feb 2026, deadline 16 Apr 2026

• HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults. c. €8m per project for up to 6 projects.
• HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions. c. €6m-€8m per project for up to 5 projects.
• HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential. c. €9m-€11m per project for up to 5 projects.
• HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic noncommunicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD). c. €3m-€4m per project for up to 5 projects.
• HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways. c. €6m-€7m per project for up to 6 projects.
• HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health. c. €1.9m for a single project.

Single-stage call opening Feb 2026, deadline 15 Sep 2026

• HORIZON-HLTH-2026-03- DISEASE-13: European Partnership for Pandemic Preparedness (Phase 2). c. €63m, over two years, for a single project.

Single-stage calls opening Feb 2027, deadline 13 Apr 2027

• HORIZON-HLTH-2027-01-DISEASE-05: Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential. c. €9m-€11m per project for up to 5 projects.
• HORIZON-HLTH-2027-01-DISEASE-06: Development of monoclonal antibodies to prevent and treat infections from Flaviviruses. c. €9m-€10m per project for up to 4 projects.
• HORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses. c. €9m-€10m per project for up to 4 projects.
• HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials. c. €8m-€10m per project for up to 5 projects.
• HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic noncommunicable diseases in children and young people (GACD). c. €3m-€4m per project for up to 3 projects.

Two-stage calls opening 10 Feb 2027, first stage deadline 13 Apr 2027, second stage 22 Sep 2027

• HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases. c. €7m-€8m per project for up to 8 projects.
• HORIZON-HLTH-2027-02-DISEASE-14- two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases. c. €10m per project for up to 4 projects.

The expected impact is that healthcare systems provide equal access to innovative, sustainable and high-quality healthcare thanks to the development and uptake of safe, cost-effective and people-centred solutions. This is to be accompanied by management models focusing on population health, health systems resilience, and health equity and patient safety, and also improved evidence-informed health policies.

Single-stage calls opening Feb 2026, deadline 16 Apr 2026

• HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens’ access to healthcare through integrated or personalised approaches. c. €3m-€8m per project for up to 4 projects.
• HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems. c. €10m per project for up to 4 projects.
• HORIZON-HLTH-2026-04-CARE-04: Enhancing and enlarging the European Partnership on Personalised Medicine (EP PerMEd) (Top-up). c. €9.8m for a single project.

Single-stage call opening Feb 2027, deadline 13 Apr 2027

• HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications. c. €8m-€10m per project for up to 4 projects.

The expected impact is that health technologies, data, new tools, and digital solutions are applied effectively thanks to their inclusive, ethically sound, secure and sustainable delivery, integration and deployment in health policies and in health and care systems.

Single-stage calls opening Feb 2026, deadline 16 Apr 2026

• HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing. c. €5m-€8m per project for up to 7 projects.
• HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine. c. €6m-€8m per project for up to 4 projects.
• HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices. c. €2.9m for a single project.
• HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs). c. €3.9m for a single project.

Two-stage calls opening 10 Feb 2027, first stage deadline 13 Apr 2027, second stage 22 Sep 2027

• HORIZON-HLTH-2027-02-TOOL-01-twostage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic noncommunicable diseases. c. €6m-€8m per project for up to 6 projects.

Single-stage calls opening Jun 2027, deadline 22 Sep 2027

• HORIZON-HLTH-2027-03-TOOL-02: Advancing bio-printing of living cells for regenerative medicine. c. €7m-€10m per project for up to 4 projects.
• HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis. c. €10m-€12m per project for up to 4 projects.
• HORIZON-HLTH-2027-03-TOOL-08: Towards Artificial General Intelligence (AGI) for healthcare. c. €2.9m for a single project.

The expected impact is that the EU health industry is innovative, sustainable, and globally competitive thanks to improved uptake of breakthrough technologies and innovations (including social innovations) that make the EU with its Member States and Associated Countries more resilient and less reliant on imports of critical health technologies.

Single-stage call opening Feb 2026, deadline 16 Apr 2026

• HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies. c. €4m-€6m per project for up to 4 projects.

Single-stage call opening Feb 2027, deadline 13 Apr 2027

• HORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for discovery and/or production of biologicals. c. €6m-€8m per project for up to 4 projects.

Two-stage calls opening 10 Feb 2027, first stage deadline 13 Apr 2027, second stage 22 Sep 2027

• HORIZON-HLTH-2027-02-IND-02-twostage: Portable and versatile Point-of-care diagnostics. c. €5m-€7m per project for up to 6 projects.